Showing results (121-130 of 404) with videos related to
Sort By:
Pageof 41
Journal of Huntington'S Disease|August 21, 2023
Sleep, Circadian Rhythms, and Cognitive Dysfunction in Huntington's DiseaseEmily S Fitzgerald, Julie C Stout, Yifat Glikmann-Johnston, et al.Behavioural Brain Research|May 9, 2012
Frontal and parietal activity after sleep deprivation is dependent on task difficulty and can be predicted by the fMRI response after normal sleepKaren E Lythe, Steven C R Williams, Clare Anderson, et al.Internal Medicine Journal|September 12, 2019
Recommendations for current and future countermeasures against sleep disorders and sleep loss to improve road safety in AustraliaAlexander P Wolkow, Shantha M W Rajaratnam, Clare Anderson, et al.Annals of Surgical Oncology|August 15, 2012
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United StatesKaren L Sherman, Ryan P Merkow, Karl Y Bilimoria, et al.International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial DesignLawrence R Kleinberg, Paul J Catalano, Arlene A Forastiere, et al.Journal of the National Cancer Institute|August 8, 2002
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancerA David McCollum, Paul J Catalano, Daniel G Haller, et al.International Journal of Radiation Oncology, Biology, Physics|August 30, 2008
Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297David I Rosenthal, Paul J Catalano, Daniel G Haller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Impact of diabetes mellitus on outcomes in patients with colon cancerJeffrey A Meyerhardt, Paul J Catalano, Daniel G Haller, et al.Cancer|July 25, 2003
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinomaJeffrey A Meyerhardt, Paul J Catalano, Daniel G Haller, et al.The Oncologist|August 7, 2014
Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review studyJonathan R Strosberg, Al B Benson, Lynn Huynh, et al.Pageof 41